Abstract
Cannabinoids are well known for their effects on neurotransmission in the central nervous system. Whereas the components of cannabinoid signaling have been intensively studied in neurons, recent data suggest that a cannabinoid signaling system, i.e. the endogenous cannabinoid ligands, the receptors that they activate and the components that degrade them, also exist in the non-neuronal cells of the brain, the glia. Because of their abundance and because of their importance in maintaining brain homeostasis, glial cells are involved in and affected by virtually all neurological diseases. Interestingly, a lot of neurological conditions, chronic and acute, are associated with a disturbance of the endocannabinoid system. This raises the possibility that effects of cannabinoids on glial cells have an important impact in these conditions and could potentially be exploited therapeutically. Cannabinoids regulate various physiological functions of glial cells, such as glucose metabolism and gap junction permeability and also have a major influence on pathophysiological functions of glial cells, like migration, cytokine production and nitric oxide release. In this review we summarize the current knowledge about cannabinoids and glial cells with a special focus on neurological conditions, especially neurodegenerative, demyelinating and neoplastic diseases.
Keywords: cannabinoids, endocannabinoids, glial cells, astrocytes, oligodendrocytes, microglia
Current Neuropharmacology
Title: Cannabinoid Signaling in Glial Cells in Health and Disease
Volume: 2 Issue: 1
Author(s): Anke Witting and Nephi Stella
Affiliation:
Keywords: cannabinoids, endocannabinoids, glial cells, astrocytes, oligodendrocytes, microglia
Abstract: Cannabinoids are well known for their effects on neurotransmission in the central nervous system. Whereas the components of cannabinoid signaling have been intensively studied in neurons, recent data suggest that a cannabinoid signaling system, i.e. the endogenous cannabinoid ligands, the receptors that they activate and the components that degrade them, also exist in the non-neuronal cells of the brain, the glia. Because of their abundance and because of their importance in maintaining brain homeostasis, glial cells are involved in and affected by virtually all neurological diseases. Interestingly, a lot of neurological conditions, chronic and acute, are associated with a disturbance of the endocannabinoid system. This raises the possibility that effects of cannabinoids on glial cells have an important impact in these conditions and could potentially be exploited therapeutically. Cannabinoids regulate various physiological functions of glial cells, such as glucose metabolism and gap junction permeability and also have a major influence on pathophysiological functions of glial cells, like migration, cytokine production and nitric oxide release. In this review we summarize the current knowledge about cannabinoids and glial cells with a special focus on neurological conditions, especially neurodegenerative, demyelinating and neoplastic diseases.
Export Options
About this article
Cite this article as:
Witting Anke and Stella Nephi, Cannabinoid Signaling in Glial Cells in Health and Disease, Current Neuropharmacology 2004; 2 (1) . https://dx.doi.org/10.2174/1570159043476855
DOI https://dx.doi.org/10.2174/1570159043476855 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
Call for Papers in Thematic Issues
Advances in Neuroinflammation and Neuroprotection: Mechanisms and Therapeutic Frontiers
It offers a comprehensive exploration of neuroinflammatory and neuroprotective pathways that play central roles in a range of neurological disorders, including stroke, traumatic brain injury, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. This issue invites research on the cellular and molecular mechanisms driving neuroinflammation, such as the roles of ...read more
Advances in paediatric and adult brain cancers: emerging targets and treatments
Brain tumors are the most common solid tumors affecting children and adolescents, with up to 5,000 children diagnosed per year. Pediatric brain tumors, because of their location, are often untreatable and their clinical management can cause significant long-term impairment to intellectual and neurological function with epilepsy and neurodegeneration. Other than ...read more
Emotion (Dys)regulation: An integration of Pharmacological, Neurobiological, and Psychological Frameworks
Emotion regulation is a critical aspect of mental well-being and interpersonal relationships. To fully understand and effectively address emotion regulation, an integrative approach that considers pharmacological, neurobiological, and psychological frameworks is essential. Pharmacological interventions, such as medications targeting neurotransmitter imbalances, can play a significant role in managing emotional dysregulation. Understanding ...read more
Enhancing Neuropharmacology with Home Cage Monitoring, Advanced Delivery and Stimulation Technologies, and Artificial Intelligence
Home cage monitoring (HCM) technologies have revolutionized neuropharmacological research by enabling continuous, non-invasive observation of rodents in their natural environments. Complementary advancements such as 24/7 continuous drug delivery systems (e.g., implantable pumps) and wireless neurostimulation methods—including optogenetics—offer precise methods for modulating neural activity and administering pharmacological agents without disrupting the ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antileukemic Properties of Sesquiterpene Lactones: A Systematic Review
Anti-Cancer Agents in Medicinal Chemistry Circulating Biomarkers for Tumor Angiogenesis: Where Are We?
Current Medicinal Chemistry Recent Advances in Experimental Molecular Therapeutics for Malignant Gliomas
Current Medicinal Chemistry - Anti-Cancer Agents Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer
Anti-Cancer Agents in Medicinal Chemistry The Quinoline Imidoselenocarbamate EI201 Blocks the AKT/mTOR Pathway and Targets Cancer Stem Cells Leading to a Strong Antitumor Activity
Current Medicinal Chemistry Artesunate Inhibits the Growth of Insulinoma Cells <i>via</i> SLC7A11/ GPX4-mediated Ferroptosis
Current Pharmaceutical Design Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia
Current Pharmaceutical Design Advances in Imaging Gene-Directed Enzyme Prodrug Therapy
Current Pharmaceutical Biotechnology Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in Cancer
Current Vascular Pharmacology Effect of MRJF4 on C6 Glioma Cells Proliferation and Migration
Central Nervous System Agents in Medicinal Chemistry DAB389EGF Fusion Protein Therapy of Refractory Glioblastoma Multiforme
Current Pharmaceutical Biotechnology Emerging Roles of microRNAs in Neural Stem Cells
Current Stem Cell Research & Therapy A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia
Current Medicinal Chemistry Active-Targeted Nanotherapy Strategies for Prostate Cancer
Current Cancer Drug Targets Effects of Glutamine Synthetase on Neovascularization in Glioma: In Vivo MR Vessel Size Imaging and Histology
Current Medical Imaging Recent Insights into Nanoparticulate Carrier Systems of Curcumin and its Clinical Perspective in the Management of Various Health Issues
Current Pharmaceutical Design Epidermal Growth Factor Receptor and its Trafficking Regulation by Acetylation: Implication in Resistance and Exploring the Newer Therapeutic Avenues in Cancer
Current Topics in Medicinal Chemistry EDITORIAL [Hot topic: New Therapeutic Advances and Perspectives in Tumour Angiogenesis (Guest Editor: Eddy Pasquier)]
Current Cancer Drug Targets Overview of the Structure and Function of Protein Kinases
Current Enzyme Inhibition The Current WHO Classification of Tumours of the Central Nervous System: Histopathology and Additional Diagnostic Methods
Current Medical Imaging